Skip to main content
. Author manuscript; available in PMC: 2010 Jan 5.
Published in final edited form as: Am J Rhinol. 2006 Sep–Oct;20(5):534–539. doi: 10.2500/ajr.2006.20.2941

Table 3.

Ranking of the incidence of simultaneous skewing in CD4+ and CD8+ T-cell subsets

Vβ Number of Subjects Expressing Both
CD4+ and CD8+ Skewed Vβs
Association to S. aureus SAg’s
Strong Weak
17 4 (20%) SEB, SEC2
12 3 (15%) SED SEC1, SEC2, SEC3, SEG
21.3 3 (15%) SEQ
8 2 (10%) SEE SED,
23 2 (10%) SEA, SEI
3 2 (10%) SEB, SEC1 SEG
5.2 2 (10%) SEK
13.1 2 (10%) SEC2 SEG
5.1 2 (10%) SEI SEC3, SEE, SEK, SEQ
5.3 1 (5%) SEA, SED SEI
2 1 (5%) TSST1 SEB, SEQ
1 1 (5%) SEA, SEB, SED, SEI
20 1 (5%) SEC2
14 0 SEG SEC2
13.2 0 SEG
9 0 SEA

Table depicts the ranking of simultaneous skewing in 16 of 24 specific Vβs analyzed based on frequency. Both strong and weak S. aureus SAg associations are shown. Some subjects expressed more than one Vβ-skewing. In these 20 subjects, 7 (35%) had skewed distributions for one or more Vβ related to a strong SAg effect.

SE(A–Q) = Staphylococcal Enterotoxin (A–Q); TSST1 = Toxic Shock Syndrome Toxin-1.